TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.

Geert Leroux-Roels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.